Related Experiment Video
Updated: Jan 5, 2026

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes
Published on: January 12, 2024
Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain
1Pharmaceutical Discovery Division, Abbott Laboratories, Abbott Park, Illinois 60064, USA.
Abstract:
The inhibitor-of-apoptosis proteins (IAPs) regulate programmed cell death by inhibiting members of the caspase family of enzymes. Recently, a mammalian protein called Smac (also named DIABLO) was identified that binds to the IAPs and promotes caspase activation. Although undefined in the X-ray structure, the amino-terminal residues of Smac are critical for its function. To understand the structural basis for molecular recognition between Smac and the IAPs, we determined the solution structure of the BIR3 domain of X-linked IAP (XIAP) complexed with a functionally active nine-residue peptide derived from the N terminus of Smac. The peptide binds across the third beta-strand of the BIR3 domain in an extended conformation with only the first four residues contacting the protein. The complex is stabilized by four intermolecular hydrogen bonds, an electrostatic interaction involving the N terminus of the peptide, and several hydrophobic interactions. This structural information, along with the binding data from BIR3 and Smac peptide mutants reported here, should aid in the design of small molecules that may be used for the treatment of cancers that overexpress IAPs.
Insights
Smac (DIABLO) binding to inhibitor-of-apoptosis proteins (IAPs) is crucial for activating caspases. This study reveals the structure of a Smac peptide bound to the BIR3 domain of XIAP, aiding cancer therapy development.
Area of Science:
- Biochemistry
- Structural Biology
- Molecular Biology
Background:
- Inhibitor-of-apoptosis proteins (IAPs) are key regulators of programmed cell death, inhibiting caspases.
- Smac (DIABLO) antagonizes IAPs, promoting caspase activation and apoptosis.
- The N-terminal residues of Smac are essential for its function, but their structural role in IAP binding is unclear.
Purpose of the Study:
- To elucidate the structural basis of molecular recognition between Smac and IAPs.
- To determine the solution structure of the BIR3 domain of XIAP complexed with a Smac-derived peptide.
Main Methods:
- Nuclear Magnetic Resonance (NMR) spectroscopy to determine the solution structure.
- Site-directed mutagenesis to analyze Smac peptide and XIAP BIR3 domain interactions.
Main Results:
- The nine-residue Smac peptide adopts an extended conformation, binding across the third beta-strand of the XIAP BIR3 domain.
- Only the N-terminal four residues of the Smac peptide directly interact with the BIR3 domain.
- The complex is stabilized by hydrogen bonds, electrostatic interactions, and hydrophobic interactions.
Conclusions:
- The determined structure provides critical insights into Smac-IAP molecular recognition.
- This structural information can guide the design of small molecules targeting IAPs for cancer therapy.
More Related Videos
10:17Creating Highly Specific Chemically Induced Protein Dimerization Systems by Stepwise Phage Selection of a Combinatorial Single-Domain Antibody Library
Published on: January 14, 2020
10:28Expression, Purification, and Liposome Binding of Budding Yeast SNX-BAR Heterodimers
Published on: December 6, 2019
Related Concept Videos
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
The JAK-STAT Signaling Pathway